The facility will complement the company’s existing manufacturing base and will help meet increased demand from its fast-growing regulated markets business across the US, Australia, the UK and Europe, it added.
Original source: https://health.economictimes.indiatimes.com/news/pharma/strides-pharma-gets-usfda-nod-for-singapore-facility/68599054?utm_source=RSS&utm_medium=ETRSS